# FDA Inspection 1155249 - Octapharma Plasma Inc - October 14, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/751857bd-aa40-49bb-ab06-9119af8c619c
Source feed: FDA_Inspections

> FDA Inspection 1155249 for Octapharma Plasma Inc on October 14, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155249
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1155249 - 2021-10-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bc88c888-fc2d-4d93-b43b-7064ac8573b5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/644c1304-c370-4417-ac45-a153aca4e966

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d